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ABSTRACT
INTRODUCTION: There is substantial evidence of the association between mental disorders and low folic acid lev-
els. The aim of this study was to evaluate the prevalence of folic acid deficiency in a sample of Portuguese psychiat-
ric outpatients.
METHODS: The study was retrospective and included 428 psychiatric outpatients with a diagnosis of depression 
or non-affective psychosis, for whom folic acid levels had been measured as part of routine blood tests. Folic acid 
levels from other hospital patients from the same time period were also registered.
RESULTS AND DISCUSSION: The prevalence of folic acid deficiency in this sample is 18%. Non-psychiatric hospital 
patients with risk factors for folic acid deficiency have a prevalence of 15% of folic acid deficiency. Men and younger 
patients have lower folic acid levels, with statistical significance, and the prevalence of deficit reached 26%. 
CONCLUSION: The elevated frequency of folic acid deficiency in this sample of patients shows that folic acid levels 
should be routinely assessed in every patient with depression or psychosis, in order to avoid maintenance of symp-
toms and treatment resistance.
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RESUMO
INTRODUÇÃO: Há múltiplas evidências da associação entre doenças mentais e baixos níveis de ácido fólico. O objetivo 
deste estudo foi avaliar a prevalência da deficiência de ácido fólico numa amostra de doentes da consulta externa de psiqui-
atria.
MÉTODOS: O estudo foi retrospetivo e incluiu 428 doentes da consulta externa de psiquiatria com os diagnósticos de de-
pressão ou de psicose não afetiva, nos quais os níveis de ácido fólico tinham sido avaliados em análises de rotina. Foram 
também registados os níveis de ácido fólico de outros doentes do hospital, no mesmo período temporal.
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RESULTADOS E DISCUSSÃO: A prevalência de deficiência de ácido fólico nesta amostra foi de 18%. Os doentes não psiquiátri-
cos com fatores de risco para deficiência de ácido fólico tiveram uma prevalência de 15% de deficiência. Nos homens e em 
doentes mais jovens os níveis de ácido fólico foram significativamente mais baixos, a prevalência de deficiência atingiu os 26%.
CONCLUSÃO: A alta frequência de deficiência de ácido fólico nesta amostra de doentes comprova que os níveis de ácido fóli-
co devem ser avaliados sistematicamente em doentes da consulta de psiquiatria com diagnósticos de depressão ou psicose, 
para evitar persistência de sintomas e resistência ao tratamento.
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INTRODUCTION 
Folic acid is a vitamin involved in one-carbon transfer 
(methylation) reactions, necessary for the production of 
monoamine neurotransmitters, phospholipids and nu-
cleotides. There is substantial evidence of the associa-
tion between mental disorders and low folic acid levels.1 
Decreased folic acid levels have also been associated 
with lowered response rates to treatment and place pa-
tients at higher risk of relapse.2
It has been hypothesized that in mental illness, a combi-
nation of decreased appetite, decreased absorption and 
increased utilization of folate results in folate depletion.3 
Mental illness is also commonly associated with alcohol 
excess, which is known to impair folate absorption and 
deplete stores of folate. Both of these factors could con-
found the relationship between folate and psychiatric 
illness, so that the direction of cause and effect remains 
unclear.4 
Research on the association of folic acid deficiency and 
mental illness dates back to the 1960s with studies 
showing reduced folic acid levels in psychiatric patients, 
the frequency varying from one quarter to one third of 
the populations studied.1 In a study made in Israel pub-
lished in 2005, 30% of psychiatric inpatients had folate 
deficiency, compared with 2.5% in the control group.4 
A study made with 70 Spanish psychiatric inpatients in 
2009 also showed significantly lower levels of folate in 
patients when compared with controls.5
A meta-analysis published in 2007 showed a signifi-
cant relationship between folate status and depression, 
which remained after controlling for potential con-
founding factors - age, nutritional status and co-morbid 
alcohol disorders.6 A meta-analysis published in 2016 
showed that folate deficiency is associated with schizo-
phrenia diagnosis.7
The aim of this study is to evaluate the prevalence of 
folic acid deficiency in a sample of Portuguese psychi-
atric outpatients and to correlate it with demographic 
factors.
METHODS
The study was retrospective, from April 2013 to De-
cember 2015, and included 428 psychiatric outpatients 
with a diagnosis of depression (unipolar, bipolar) or 
non-affective psychosis (schizophrenia, delusional dis-
order, transient and acute psychosis) for whom folic acid 
levels had been measured as part of routine blood tests 
in the outpatient clinic. Folic acid was measured in plas-
ma by immunoassay, levels below 3 ng/mL were consid-
ered deficient.
Folic acid levels from other hospital patients from the 
same time period were also gathered a total of 1271 
patients, to serve as comparison. These were from in-
patients and outpatients from neurology, internal med-
icine, surgery and gastroenterology, whose doctors re-
quested folic acid levels for clinical reasons.
The statistical analysis was made with IBM SPSS Statis-
tics 24.
RESULTS
Psychiatric patients’ mean age was 48, 75% of the sam-
ple were women and 70% had a diagnosis of depression. 
Mean folic acid levels was 6.5 ng/mL. Values were low-
er in men, patients with psychosis and patients younger 
than 48 (patients were divided in two groups using as a 
cut off the mean age of 48, for analysis purposes). The 
global prevalence of folic acid deficiency was 18%, with 
a maximum of 26% in men and in patients younger than 
48, and a minimum of 12% in older patients (Table 1). 
These differences were statistically significant, but when 
sex and age were controlled, there were no significant 
differences in folic acid levels between depression and 
psychosis patients, as the differences found were due 
to different demographics in different diagnostic groups 
(Table 2).
Non-psychiatric hospital patients for whom folic acid 
was measured served as a comparison group. Their 
mean folic acid level was 7.8 ng/mL, younger patients 
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criteria for patient selection, methods of measurement 
and definitions of folic acid deficiency vary considerably. 
Non-psychiatric hospital patients had a prevalence of 
15%. These patients are, however, at high risk for folic 
acid deficiency, as they have diagnosis such as macrocyt-
ic anaemia, liver cirrhosis, malabsorption or dementia. 
The conclusion to be drawn from these results is that 
psychiatric patients with depression or psychosis are 
also a high risk group for folic acid deficiency.
Men, younger patients and non-affective psychosis pa-
tients had lower folic acid levels when compared with 
women, older patients and patients with diagnosis of de-
pression, and the difference was statistically significant. 
However, when sex and age were controlled, there was 
no difference in folic acid levels between depression and 
psychosis patients – as patients with psychosis are usu-
ally younger and more frequently male. 
In non-psychiatric patients only age was a risk factor for 
folic acid deficiency, with younger patients having lower 
levels of folic acid and higher percentages of folic acid de-
ficiency. In this group of patients, male sex was not a risk 
factor for folic acid deficiency when age is controlled.
The differences found may be explained by the high-
er prevalence of risk factors for folic acid deficiency in 
younger and in male patients, accentuated in mental 
illness - poor nutrition, alcohol abuse, medication with 
mood-stabilizing anticonvulsants.  
The elevated frequency of folic acid deficiency in this 
sample shows that folic acid levels should be routinely 
assessed in every patient with depression or psychosis, 
in order to avoid maintenance of symptoms and treat-
ment resistance.
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Total (428) 48 y 6.5 18%
Men (109) 44 4.9 (t – -4.586) 26%
Women 




5.3 (t – 4.752 26%
Older than 
48 (233) 7.5 (p – 0.000) 12%
Psychosis 
(129) 44 5.5 (t – 3.082) 23%
Depression 
(299) 50 6.9 (p – 0.002) 16%
TABLE 2. Analysis of regression of folic acid levels.
Folic acid levels by: β SE t p
Sex -1.607 .562 -2.857 .004
Age .065 .015 4.393 .000
Diagnostic -.441 .538 -.819 .413









Total (1271) 61 7.8 15%
Men (542) 61 7.6 (t – -1.148 15%
Women 




5.9 (t – -6.734 27%
Older than 
48 (972) 8.3 p – 0.000) 11%
also had lower levels, with a statistically significant dif-
ference, but there was no statistically significant differ-
ence in levels between men and women. The prevalence 
of folic acid deficiency was 15%, with a maximum of 27% 
in patients younger than 48 (Table 3).
DISCUSSION 
AND CONCLUSION
The prevalence of folic acid deficiency in this sample was 
18%, similar to the prevalence obtained in other stud-
ies, but data are not comparable as the methodology, 
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